UnitedHealth Group (NYSE:UNH), Humana (NYSE:HUM), and CVS Health (NYSE:CVS), which own Aetna, are seen as managed care providers set to benefit the most should former President Donald Trump win a second term in November.
RBC Capital Markets on Friday released a note stating that following Thursday night's debate between Trump and President Joe Biden, they see a more favorable regulatory environment under a Trump presidency.
"A second Trump term would ease regulatory and reimbursement headwinds weighing on the managed care stocks, particularly the Medicare Advantage leaders UNH, HUM, and CVS," analyst Ben Hendrix wrote.
"Among the MCOs, we see the most immediate upside for UNH as we believe a Trump administration would also ease DOJ scrutiny around Optum and vertical integration between health plans and Optum Health's primary are platform," he added.